Louise Linde

Direct comparison of treatment responses, remission rates, and drug adherence in patients with rheumatoid arthritis treated with adalimumab, etanercept, or infliximab: Results from eight years of surveillance of clinical practice in the nationwide Danish DANBIO registry

Merete Lund Hetland, Ib Jarle Christensen, Ulrik Tarp et al. · Arthritis & Rheumatism · 2009 · 529 citations

Health-related quality of life: validity, reliability, and responsiveness of SF-36, 15D, EQ-5D [corrected] RAQoL, and HAQ in patients with rheumatoid arthritis.

Louise Linde, Jan Sørensen, Mikkel Østergaard et al. · PubMed · 2008 · 227 citations

Incidences of overall and site specific cancers in TNFα inhibitor treated patients with rheumatoid arthritis and other arthritides – a follow-up study from the DANBIO Registry

Lene Dreyer, Lene Mellemkjær, Anne Rødgaard Andersen et al. · Annals of the Rheumatic Diseases · 2012 · 175 citations · Full text

Interleukin-6-receptor polymorphisms rs12083537, rs2228145, and rs4329505 as predictors of response to tocilizumab in rheumatoid arthritis

Christian Enevold, Bo Baslund, Louise Linde et al. · Pharmacogenetics and Genomics · 2014 · 47 citations

Inflammation, Rheumatology, Rheumatoid Disorder +15

Does Clinical Remission Lead to Normalization of EQ-5D in Patients with Rheumatoid Arthritis and Is Selection of Remission Criteria Important?

Louise Linde, Jan Sørensen, Mikkel Østergaard et al. · The Journal of Rheumatology · 2010 · 47 citations · Full text

Quality Of Life, Disease Progression, Immunology +25